Welcome to the UPF Digital Repository

Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall

Show simple item record

dc.contributor.author Vernet-Tomás, Maria
dc.contributor.author Louro, Javier
dc.contributor.author Román, Marta
dc.contributor.author Saladié, Francina
dc.contributor.author Posso, Margarita
dc.contributor.author Prieto, Miguel
dc.contributor.author Vázquez, Ivonne
dc.contributor.author Baré, Marisa
dc.contributor.author Peñalva, Lupe
dc.contributor.author Vidal, Carmen
dc.contributor.author Bargalló Castelló, Xavier
dc.contributor.author Sánchez, Mar
dc.contributor.author Ferrer, Joana
dc.contributor.author Espinàs, Josep Alfons
dc.contributor.author Quintana, María Jesús
dc.contributor.author Rodríguez Arana, Ana Maria
dc.contributor.author Castells, Xavier
dc.contributor.author BELE Study Group
dc.date.accessioned 2021-09-28T06:19:20Z
dc.date.issued 2021
dc.identifier.citation Vernet-Tomás M, Louro J, Román M, Saladié F, Posso M, Prieto M, Vázquez I, Baré M, Peñalva L, Vidal C, Bargalló X, Sánchez M, Ferrer J, A Espinàs J, Quintana MJ, Rodríguez-Arana A, Castells X; BELE study group. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall. Maturitas. 2021;144:53-9. DOI: 10.1016/j.maturitas.2020.10.024
dc.identifier.issn 0378-5122
dc.identifier.uri http://hdl.handle.net/10230/48512
dc.description.abstract Objective: We aimed to explore whether the type of mammographic feature prompting a false-positive recall (FPR) during mammography screening influences the risk and timing of breast cancer diagnosis, particularly if assessed with invasive procedures. Study design: We included information on women screened and recalled for further assessment in Spain between 1994 and 2015, with follow-up until 2017, categorizing FPRs by the assessment (noninvasive or invasive) and mammographic feature prompting the recall. Main outcome measures: Breast cancer rates in the first two years after FPR (first period) and after two years (second period). Results: The study included 99,825 women with FPRs. In both periods, the breast cancer rate was higher in the invasive assessment group than in the noninvasive group (first period 12 ‰ vs 1.9 ‰, p < 0.001; second period 4.4‰ vs 3.1‰, p < 0.001). During the first period, the invasive assessment group showed diverse breast cancer rates for each type of mammographic feature, with a higher rate for asymmetric density (31.9‰). When the second period was compared with the first, the breast cancer rate decreased in the invasive assessment group (from 12‰ to 4.4‰, p < 0.001) and increased in the noninvasive assessment group (from 1.9‰ to 3.1‰, p < 0.001). Conclusion: In the context of mammography screening, the risk of breast cancer diagnosis during the first two years after FPR was particularly high for women undergoing invasive assessment; importantly, the risk was modified by type of mammographic feature prompting the recall. This information could help to individualize follow-up after exclusion of malignancy.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Maturitas. 2021;144:53-9
dc.rights © Elsevier http://dx.doi.org/10.1016/j.maturitas.2020.10.024
dc.title Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.maturitas.2020.10.024
dc.subject.keyword Breast cancer screening
dc.subject.keyword Breast cancer risk
dc.subject.keyword False-positive recall
dc.subject.keyword Invasive assessment
dc.subject.keyword Mammographic feature
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


Compliant to Partaking